These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 8152798

  • 1. Sequence specificity in the recognition of the epidermal growth factor receptor by the abl Src homology 2 domain.
    Zhu G, Decker SJ, Maclean D, McNamara DJ, Singh J, Sawyer TK, Saltiel AR.
    Oncogene; 1994 May; 9(5):1379-85. PubMed ID: 8152798
    [Abstract] [Full Text] [Related]

  • 2. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S.
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [Abstract] [Full Text] [Related]

  • 3. Structural basis of interactions between epidermal growth factor receptor and SH2 domain proteins.
    Sierke SL, Longo GM, Koland JG.
    Biochem Biophys Res Commun; 1993 Feb 26; 191(1):45-54. PubMed ID: 7680558
    [Abstract] [Full Text] [Related]

  • 4. Differentiation of peptide molecular recognition by phospholipase C gamma-1 Src homology-2 domain and a mutant Tyr phosphatase PTP1bC215S.
    MacLean D, Sefler AM, Zhu G, Decker SJ, Saltiel AR, Singh J, McNamara D, Dobrusin EM, Sawyer TK.
    Protein Sci; 1995 Jan 26; 4(1):13-20. PubMed ID: 7773170
    [Abstract] [Full Text] [Related]

  • 5. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
    Van Etten RA, Debnath J, Zhou H, Casasnovas JM.
    Oncogene; 1995 May 18; 10(10):1977-88. PubMed ID: 7539119
    [Abstract] [Full Text] [Related]

  • 6. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
    Oda T, Kujovich J, Reis M, Newman B, Druker BJ.
    Oncogene; 1997 Sep 18; 15(11):1255-62. PubMed ID: 9315092
    [Abstract] [Full Text] [Related]

  • 7. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB, Roumiantsev S, Van Etten RA.
    Oncogene; 2001 Nov 22; 20(53):7744-52. PubMed ID: 11753652
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protein tyrosine kinase-substrate interactions.
    Bose R, Holbert MA, Pickin KA, Cole PA.
    Curr Opin Struct Biol; 2006 Dec 22; 16(6):668-75. PubMed ID: 17085043
    [Abstract] [Full Text] [Related]

  • 10. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Barilá D, Superti-Furga G.
    Nat Genet; 1998 Mar 22; 18(3):280-2. PubMed ID: 9500553
    [Abstract] [Full Text] [Related]

  • 11. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT, Serrano L, Wilmanns M.
    J Mol Biol; 1998 Aug 21; 281(3):513-21. PubMed ID: 9698566
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2.
    Charest A, Wagner J, Kwan M, Tremblay ML.
    Oncogene; 1997 Apr 10; 14(14):1643-51. PubMed ID: 9135065
    [Abstract] [Full Text] [Related]

  • 17. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM, Mitaxov V, Waksman G.
    J Mol Biol; 1999 Nov 05; 293(4):971-85. PubMed ID: 10543978
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
    Nagar B, Hantschel O, Seeliger M, Davies JM, Weis WI, Superti-Furga G, Kuriyan J.
    Mol Cell; 2006 Mar 17; 21(6):787-98. PubMed ID: 16543148
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.